Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Biogen Idec (BIIB)

2014-07-23@20:52:49 ET
Biogen IdecCorporate Event Announcement Notice (WSH)

2014-07-23@18:11:11 ET
Mixed Session, Getting a Little Long in the Tooth (ETF)

2014-07-23@16:38:44 ET
Watch for Biogen Idec to Potentially Pullback After Gaining 11.17% Yesterday (PSM)

2014-07-23@16:38:13 ET
Biogen Idec Set to Possibly Pullback After Yesterday's Rally of 11.17% (PSM)

2014-07-23@16:24:20 ET

2014-07-23@16:10:19 ET
Stocks End Mixed; Dow Struggles But S&P 500 Notches Another Record Close (MID)

2014-07-23@15:23:28 ET
Top 5 Performing S&P 500 Stocks (ISRG, BIIB, RHI, ODP, APD) (F70)

2014-07-23@14:13:24 ET
Buyers Accumulating Shares of Biogen Idec on 3.0x Above-Average Volume (BIIB) (F82)

2014-07-23@12:45:17 ET
Midday Update: Stocks Mixed with Techs, Biotechs Buoying Nasdaq, But Geo-Political Tensions Dogging Dow (MID)

2014-07-23@12:03:00 ET
Bullish Moving Average Cross by Biogen Idec (BIIB) (F78)

2014-07-23@11:41:01 ET
PLEGRIDY(TM) (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis (BIZ)

2014-07-23@09:18:49 ET
Biogen Idec (BIIB) Showing Bearish Technicals With Support At $299.36 (FBM)

2014-07-23@09:04:38 ET

2014-07-23@09:03:34 ET
US Futures Point to Higher Open Amid Slew of Solid Quarterly Earnings (MID)

2014-07-23@06:52:07 ET
Biogen Idec Raises Guidance (SEG)

2014-07-23@06:45:01 ET
Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year (BIZ)